USTEKINUMAB MAINTAINED CLINICALLY MEANINGFUL IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS FROM THE UNIFI LONG-TERM EXTENSION

被引:0
|
作者
Sandborn, William J.
Rowbotham, David
Leong, Rupert W.
Han, Chenglong
Zhou, Yiying
Zhang, Hongyan
Johanns, Jewel
Marano, Colleen W.
Danese, Silvio
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sa1807
引用
收藏
页码:S433 / S433
页数:1
相关论文
共 50 条
  • [41] Ustekinumab Improves Health-Related Quality of Life in Korean and Taiwanese Patients With Moderate to Severe Psoriasis: Results from the PEARL Trial
    Tsai, Tsen-Fang
    Song, Michael
    Shen, Yaung-Kaung
    Schenkel, Brad
    Choe, Yong-Beom
    Kim, Nack-In
    Lee, Joo-Heung
    Lee, Ju-Hee
    Song, Hae-Jun
    Youn, Jai-Il
    JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (08) : 943 - 949
  • [42] Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial
    Lebwohl, M.
    Papp, K.
    Han, C.
    Schenkel, B.
    Yeilding, N.
    Wang, Y.
    Krueger, G. G.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (01) : 137 - 146
  • [43] Ustekinumab (UST) Induced Clinically Meaningful Improvement and Remission as Measured by the Inflammatory Bowel Disease Questionnaire (IBDQ) in Patients with Moderate to Severe Ulcerative Colitis
    Marone, Colleen
    Sands, Bruce E.
    Han, Chenglong
    Zhang, Hongyan
    Johanne, Jewel
    Szapary, Philippe
    Leone, Rupert W.
    Danese, Silvio
    SWISS MEDICAL WEEKLY, 2019, : 27S - 27S
  • [44] Golimumab improves health-related quality of life of patients with moderate-to-severe ulcerative colitis: Results of the go-care study
    Saibeni, S.
    Bezzio, C.
    Bossa, F.
    Privitera, A. C.
    Marchi, S.
    Roselli, J.
    Mazzuoli, S.
    Geccherle, A.
    Soriano, A.
    Principi, M. B.
    Viola, A.
    Sarpi, L.
    Cappello, M.
    D'Inca, R.
    Mastronardi, M.
    Bodini, G.
    Guerra, M.
    Benedetti, A.
    Romano, M.
    Cicala, M.
    Di Sabatino, A.
    Scaldaferri, F.
    De Rosa, T.
    Giardino, A. M.
    Germano, V.
    Orlando, A.
    Armuzzi, A.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (01) : 83 - 91
  • [45] Corticosteroid-Sparing Effects of Ustekinumab Therapy for Ulcerative Colitis Through 4 Years: UNIFI Long-Term Extension
    Abreu, Maria T.
    Scherl, Ellen J.
    Rowbotham, David S.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Panaccione, Remo
    Afif, Waqqas
    Hisamatsu, Tadakazu
    Leong, Rupert W.
    Sands, Bruce E.
    Arasaradnam, Ramesh P.
    Marano, Colleen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S577 - S577
  • [46] Corticosteroid-sparing effects of ustekinumab therapy for Ulcerative Colitis through 3 years: UNIFI long-term extension
    Scherl, E. J.
    Rowbotham, D. S.
    Danese, S.
    Sandborn, W. J.
    Miao, Y.
    Zhang, H.
    Abreu, M. T.
    Panaccione, R.
    Afif, W.
    Hisamatsu, T.
    Leong, R. W.
    Arasaradnam, R. P.
    Sands, B. E.
    Marano, C.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S117 - S118
  • [47] Ustekinumab improves disease specific health-related quality of life in patients with moderate to severe psoriasis: Results with the dermatology life quality index
    Lebwohl, M.
    Papp, K.
    Schenkel, B.
    Eisenberg, D.
    Yeilding, N.
    Guzzo, C.
    Wang, Y.
    Li, S.
    Krueger, G. G.
    VALUE IN HEALTH, 2008, 11 (03) : A293 - A293
  • [48] Ustekinumab improves health-related quality of life in Chinese patients with moderate to severe plaque psoriasis
    Zhu Xue-jun
    Zheng Min
    Song, Michael
    Schenkel, Brad
    Yaung-Kaung Shen
    Wang Bao-xi
    JOURNAL OF DERMATOLOGY, 2012, 39 : 239 - 239
  • [49] The Effects of Ustekinumab on Health-related Quality of Life in Patients With Moderate to Severe Crohn's Disease
    Sands, Bruce E.
    Han, Chenglong
    Gasink, Christopher
    Jacobstein, Douglas
    Szapary, Philippe
    Gao, Long-Long
    Lang, Yinghua
    Targan, Stephan
    Sandborn, William J.
    Feagan, Brian G.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (08): : 883 - 895
  • [50] Early Improvement After Intravenous Ustekinumab Induction in Patients With Ulcerative Colitis: Results From the UNIFI Induction Trial
    Sands, Bruce E.
    Abreu, Maria T.
    Marano, Colleen
    Baker, Thomas
    O'Brien, Christopher
    Zhang, Hongyan
    Johanns, Jewel
    Rowbotham, David
    Leong, Rupert W. L.
    Danese, Silvio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S404 - S404